의료용 특수 백 : 시장 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, medical specialty bags market size in 2026 is estimated at USD 10.86 billion, growing from 2025 value of USD 10.40 billion with 2031 projections showing USD 13.52 billion, growing at 4.47% CAGR over 2026-2031.

This report is Segmented by Product (Intravenous Fluid Bags, Ostomy Bags, Sterile Collection & Drainage Bags, Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags, and More), Material (PVC, PE & PP, and More), End-User (Hospitals, Ambulatory & Day-Care Centers, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Medical Specialty Bags Market Trends and Insights

Rising Burden of Chronic Diseases and Surgical Procedures

Colorectal cancer and inflammatory bowel disease prevalence continues to rise, elevating permanent and temporary stoma creation volumes worldwide. Hospitals standardize pouching systems to lower readmission risks, spurring orders for leak-resistant ostomy kits that improve peristomal skin integrity. Manufacturers add hydrocolloid and silicone coupling layers to boost wear-time and comfort, encouraging patient adherence. Integrated discharge programs train patients in pouch maintenance, further anchoring recurring demand within the medical specialty bags market. These developments sustain baseline growth even when elective procedure rates fluctuate.

Accelerated Uptake of CAPD for Home Renal Therapy

Public payers in Asia-Pacific and Latin America increasingly reimburse home-based dialysis to ease inpatient bed pressure and enhance quality of life. The Carry Life UF platform underscores how precise glucose titration can increase ultrafiltration and sodium removal, helping patients stay in target fluid ranges. Training apps and tele-monitoring keep complication rates low, prompting clinicians to recommend Continuous Ambulatory Peritoneal Dialysis earlier in the treatment journey. Producers of CAPD solution and drainage bags benefit from kit bundling policies, which lock in multi-year supply contracts. Consequently, CAPD continues to be the fastest-growing product line inside the medical specialty bags market.

Reimbursement Gaps in Emerging Economies

While procedure volumes climb, many public insurers in lower-income regions do not reimburse advanced ostomy or CAPD kits in full, forcing patients to self-pay significant portions. Out-of-pocket burdens reduce uptake of premium, skin-friendly materials, dampening revenue potential for global suppliers. Insurance modernization is under way, yet inflationary pressures on health budgets prolong subsidy negotiations. Local distributors often favor low-cost PVC options, stalling adoption of greener polymers. Over time, tiered pricing models and expanded private insurance pools may narrow the gap, but near-term drag on the medical specialty bags market persists.

Other drivers and restraints analyzed in the detailed report include:

1. Transition to PVC-Free and Recyclable Polymers
2. Growth of Ambulatory Care Models and Digitalized Bag Solutions
3. Extended Regulatory Timelines for Novel Polymers

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Ostomy bags remained the largest product line with a 32.02% medical specialty bags market share in 2025 as colorectal cancer surgeries and inflammatory bowel disease resections kept stoma creation steady. Hospitals favor multi-layer barrier films that prolong wear time, lowering peristomal dermatitis incidence and reducing unscheduled clinic visits. Leading OEMs supply closed-end and drainable variants in a wide size range, which drives bulk purchasing under group contracts. Continuous innovation, including 3-D-printed convex baseplates tailored to patient anatomy, improves seal integrity and boosts brand loyalty in the broader medical specialty bags market.

The CAPD bag portfolio, by contrast, posted the fastest expansion at an 8.23% CAGR, reflecting payer incentives for home renal therapies. New low-glucose solutions extend membrane life and widen treatment eligibility for diabetic populations. Ready-to-use twin-compartment bags minimize spiking steps, reducing peritonitis risk during exchanges. Regional manufacturing hubs in India and Vietnam shorten lead times and protect supply continuity during resin shortages. As clinical specialists' education programs gain traction, CAPD adoption curves mirror insulin pump trends, signaling sustained growth beyond large urban centers.

Complete Report Scope:

• By Product
  • Intravenous (IV) Fluid Bags
  • Ostomy Bags
  • Sterile Collection & Drainage Bags
  • Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags
  • Anesthesia & Resuscitation Bags
  • Blood & Blood-Component Transfer Bags
  • Others
• By Material
  • PVC
  • PE & PP
  • EVA & Other Copolymers
  • Silicone & TPU
  • Bio-based / Compostable Polymers
• By End-user
  • Hospitals
  • Ambulatory & Day-Care Centers
  • Home-Care Settings
  • Long-term Care Facilities
• Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 35.82% of global revenue in 2025, anchored by robust insurance coverage and rapid clearance pathways that speed novel bag introductions. The region's ASC boom fuels demand for compact anesthesia and drainage sets that fit small procedure rooms, while hurricane-related factory disruptions spotlight the importance of geographic redundancy in IV bag production. Canada's national strategy to cut single-use plastics accelerates pilot programs for compostable ostomy pouches, and Mexico's maquiladora corridor supplies low-cost PVC units to both domestic and U.S. facilities, reinforcing cross-border supply resilience.

Asia-Pacific registered the fastest growth at an 8.16% CAGR, propelled by aging populations and expanding universal health coverage. China's volume-based procurement exerts downward pressure on average selling prices, yet high unit throughput preserves supplier margins. Japanese home-dialysis penetration exceeds 15%, creating early-adopter demand for automated exchange bag sets with RFID chips. India subsidizes stoma care appliances for low-income groups through state insurance schemes, broadening the base of ostomy users. Southeast Asia's medical device parks attract foreign direct investment, fostering local supply of infusion and drainage bags and cementing the region as a manufacturing pivot in the medical specialty bags market.

Europe remains a steady contributor, with stringent environmental directives pushing conversion from DEHP-plasticized PVC toward recyclable or bio-based films. Hospitals in Germany and the Nordics embed life-cycle metrics into tenders, rewarding vendors with validated carbon-footprint disclosures. France's reimbursement of home nutrition solutions boosts sales of multilayer EVA/PP bags compatible with compounding automation. The United Kingdom funds pilot studies on smart ostomy pouches that transmit fill-level data to community nurses, reducing unplanned clinic visits. Overall, the continent's policy mix of sustainability incentives and quality-of-life reimbursement preserves mid-single-digit expansion in the medical specialty bags market.

1. Ambu
2. B. Braun
3. Baxter
4. Coloplast
5. ConvaTec Group plc
6. Hollister
7. Kawasumi Laboratories
8. MacoPharma
9. Nolato
10. Danaher
11. Cardinal Health
12. Fresenius
13. Beckton Dickinson
14. Terumo
15. ICU Medical
16. Teleflex
17. Poly Medicure Ltd.
18. Weigao Group Medical Polymer Co.
19. Renolit SE

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing Burden Of Chronic Diseases & Surgeries
  • 4.2.2 Rapid Adoption Of CAPD For Home Renal Care
  • 4.2.3 Shift Toward PVC-Free & Recyclable Polymers
  • 4.2.4 Expansion Of Ambulatory & Day-Care Centers
  • 4.2.5 AI-Enabled Production Line Quality Control
  • 4.2.6 Hospital Demand For RFID-/Iot-Tagged Smart Bags
• 4.3 Market Restraints
  • 4.3.1 Reimbursement Gaps In Emerging Economies
  • 4.3.2 Long Regulatory Approval Cycles For Novel Polymers
  • 4.3.3 Volatile Prices Of Medical-Grade Resins
  • 4.3.4 Rising ESG Scrutiny On Single-Use Devices
• 4.4 Porter's Five Forces
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product
  • 5.1.1 Intravenous (IV) Fluid Bags
  • 5.1.2 Ostomy Bags
  • 5.1.3 Sterile Collection & Drainage Bags
  • 5.1.4 Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags
  • 5.1.5 Anesthesia & Resuscitation Bags
  • 5.1.6 Blood & Blood-Component Transfer Bags
  • 5.1.7 Others
• 5.2 By Material
  • 5.2.1 PVC
  • 5.2.2 PE & PP
  • 5.2.3 EVA & Other Copolymers
  • 5.2.4 Silicone & TPU
  • 5.2.5 Bio-based / Compostable Polymers
• 5.3 By End-user
  • 5.3.1 Hospitals
  • 5.3.2 Ambulatory & Day-Care Centers
  • 5.3.3 Home-Care Settings
  • 5.3.4 Long-term Care Facilities
• 5.4 Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 South Korea
    • 5.4.3.5 Australia
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Ambu A/S
  • 6.3.2 B. Braun Melsungen AG
  • 6.3.3 Baxter International Inc.
  • 6.3.4 Coloplast A/S
  • 6.3.5 ConvaTec Group plc
  • 6.3.6 Hollister Incorporated
  • 6.3.7 Kawasumi Laboratories Inc.
  • 6.3.8 Macopharma SA
  • 6.3.9 Nolato AB
  • 6.3.10 Danaher Corporation (Pall Corporation)
  • 6.3.11 Cardinal Health Inc.
  • 6.3.12 Fresenius Medical Care AG & Co. KGaA
  • 6.3.13 BD (Becton, Dickinson and Company)
  • 6.3.14 Terumo Corporation
  • 6.3.15 ICU Medical Inc.
  • 6.3.16 Teleflex Inc.
  • 6.3.17 Poly Medicure Ltd.
  • 6.3.18 Weigao Group Medical Polymer Co.
  • 6.3.19 Renolit SE

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment